Thermo Fisher Scientific (TMO) Revenue — Quarter Ended Dec 31, 2024
Revenue for the quarter increased compared to both the prior quarter and the same period a year earlier. The sequential improvement followed a pattern of modest growth in the preceding quarter.
Key takeaway
Quarter ended Dec 31, 2024 · FY2024 Q4
Revenue for the quarter increased compared to both the prior quarter and the same period a year earlier. The sequential improvement followed a pattern of modest growth in the preceding quarter.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$11.4B
Revenue reported for this quarter.
Quarter-over-quarter
+7.5%
Change from the immediately preceding quarter.
Year-over-year
+4.7%
Change from the comparable year-ago quarter.
Trailing four quarters
$42.9B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 30, 2024 | $10.3B | -3.4% |
| Jun 29, 2024 | $10.5B | -1.4% |
| Sep 28, 2024 | $10.6B | +0.2% |
| Dec 31, 2024 | $11.4B | +4.7% |
Revenue performance
The reported revenue rose from the immediately preceding quarter, marking a continuation of the upward trend seen in the prior period.
Quarterly comparison
Compared with the same quarter one year ago, revenue also increased. The sequential and year-over-year gains were both positive.
What to watch
The trajectory of sequential revenue growth may warrant attention given the earlier quarters showed declines.